查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1618547

肺癌手术市场：按手术设备、手术程序和最终用户划分 - 全球预测 2025-2030 年

Lung Cancer Surgery Market by Surgical Devices (Endo Surgical Equipment, Monitoring & Visualizing Systems, Surgical Instruments), Surgical Procedures (Minimally Invasive Surgeries, Thoracotomy), End-user - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年肺癌手术市场价值为56.9亿美元，预计到2024年将达到60.1亿美元，预计复合年增长率为5.88%，到2030年达到85亿美元。

肺癌手术的范围和定义包括旨在从肺部去除癌组织的各种外科手术。这个领域包括切除术、楔形切除术、切除术和切除术等手术，且胸腔镜手术、电视辅助胸腔镜手术（VATS）和机器人手术等微创方法都很重要。肺癌手术的必要性源自于非小细胞肺癌（NSCLC）的根治性治疗通常辅以化疗和放射线治疗。它的用途涵盖治癒性和姑息性治疗，透过手术缓解晚期癌症的症状。典型的最终使用者包括医院、专科诊所和癌症治疗中心。根据市场洞察，肺癌发病率上升、手术技术进步、微创手术的采用增加以及支持性医疗保健政策推动了成长。然而，挑战包括手术成本上升、与手术併发症相关的风险以及对熟练外科医生的需求。潜在的商机在于新兴市场、不断发展的医疗基础设施以及人工智慧和手术机器人等技术创新。建议包括扩大微创手术、加强术后护理以及重点开发具有成本效益的手术解决方案。限制来自于需要改进患者选择和更好地整合多种治疗方法。我们也面临早期诊断的挑战。创新机会包括个人化手术方法、利用基因组资料改善结果、提高手术器械精度的进步。市场竞争激烈，重点是技术进步和协作研究以优化治疗效果，而以患者为中心的方法和成本控制则推动成长。

主要市场统计
基准年[2023] 56.9亿美元
预计年份 [2024] 60.1亿美元
预测年份 [2030] 85亿美元
复合年增长率（%） 5.88%

市场动态：快速发展的肺癌手术市场的关键市场洞察

供需的动态交互作用正在改变肺癌手术市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 吸烟增加导致肺癌发生率增加
    • 越来越重视癌症的早期诊断和早期治疗
    • 更多采用微创技术
  • 市场限制因素
    • 肺癌诊治费用高
  • 市场机会
    • 肺癌治疗技术不断进步
    • 癌症治疗的报销政策和政府支持的可用性
  • 市场挑战
    • 缺乏训练有素的专业人员

波特五力：开拓肺癌手术市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解肺癌手术市场的外部影响

外部宏观环境因素对肺癌手术市场的绩效动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解肺癌手术市场的竞争状况

肺癌手术市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵肺癌手术市场供应商的绩效评估

FPNV 定位矩阵是评估肺癌手术市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议绘製肺癌手术市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对肺癌手术市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 肺癌发生率上升和吸烟趋势增加
      • 癌症的早期诊断和治疗变得越来越重要
      • 更多采用微创技术
    • 抑制因素
      • 肺癌诊疗费用高昂
    • 机会
      • 肺癌治疗技术进展
      • 癌症治疗的报销政策和政府支持的可用性
    • 任务
      • 缺乏训练有素的专业人员
  • 市场区隔分析
    • 手术设备：监测和可视化系统的技术进步可改善复杂的肺癌手术过程
    • 手术：肺癌微创手术因其减轻疼痛和恢復更快的优点而越来越受到青睐。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章肺癌手术市场手术设备

  • 末端手术设备
  • 监控及视觉化系统
    • 相机和视频支持
    • 具有光学视野的内视镜套管针
  • 手术器械
    • 手用仪器
      • 夹钳
      • 刀具
      • 电梯
      • 钳子
      • 牵开器
      • 肋骨剪刀
      • 剪刀
      • 订书机
      • 套管针
    • 电动手术设备

第七章依手术方式分類的肺癌手术市场

  • 微创手术
  • 开胸手术
    • 切除术
    • 肺切除术
    • 部分切除术
    • 袖状切除术

第八章肺癌手术市场：依最终用户分类

  • 医院
  • 专业癌症治疗中心

第九章北美及南美肺癌手术市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太肺癌手术市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲肺癌手术市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 诺华收购 Mariana Oncology 增强癌症治疗能力
    • Harmonic 临床试验的扩展，东亚非吸烟者非小细胞肺癌治疗的新领域
    • 开创性的移植计画为第四期肺癌患者带来新的生命
  • 战略分析和建议

公司名单

  • Accuray Inc.
  • Ackermann Instrumente GmbH
  • AngioDynamics Inc.
  • Baxter Healthcare Corporation
  • FusionKraft Surgical Instruments
  • Henry Schein, Inc.
  • Intuitive Surgical Inc.
  • Johnson & Johnson Services, Inc.
  • KARL STORZ GmbH
  • Key Surgical LLC by STERIS plc
  • KLS Martin Group
  • Koninklijke Philips NV
  • Medtronic PLC
  • Olympus Corporation
  • Richard Wolf GmbH
  • Scanlan International Inc.
  • Siemens Healthineers AG
  • Sontec Instruments Inc.
  • Teleflex Incorporated
  • TROKAMED GmbH
  • Wexler Surgical Inc.
Product Code: MRR-501246436957

The Lung Cancer Surgery Market was valued at USD 5.69 billion in 2023, expected to reach USD 6.01 billion in 2024, and is projected to grow at a CAGR of 5.88%, to USD 8.50 billion by 2030.

The scope and definition of lung cancer surgery encompass various surgical procedures aimed at removing cancerous tissues from the lungs, which is critical in managing early-stage lung cancers and improving survival rates. This field involves techniques such as lobectomy, wedge resection, segmentectomy, and pneumonectomy, with thoracotomy and minimally invasive approaches like video-assisted thoracoscopic surgery (VATS) and robotic surgery being crucial. The necessity of lung cancer surgery arises from its role as a curative treatment for non-small cell lung cancer (NSCLC) in localized stages, often complemented by chemotherapy or radiotherapy. Its application extends to both curative and palliative care, where surgery alleviates symptoms in advanced cancer stages. The main end-users include hospitals, specialty clinics, and cancer care centers. Market insights suggest growth is driven by rising lung cancer prevalence, advancements in surgical techniques, increasing adoption of minimally invasive surgeries, and supportive healthcare policies. However, challenges include high surgical costs, risks related to surgical complications, and the need for highly skilled surgeons. Potential opportunities lie in emerging markets, growing healthcare infrastructure, and technological innovations like AI and robotics in surgery. Recommendations include focusing on expanding minimally invasive procedures, enhancing post-surgical care, and developing cost-effective surgical solutions. Limitations stem from the need for improved patient selection and better integration of multimodal therapies. The market also faces the challenge of early diagnosis, which is vital for surgical eligibility. Innovation opportunities exist in personalized surgery approaches, leveraging genomic data to improve outcomes, and advancements in surgical tools enhancing precision. The nature of the lung cancer surgery market is competitive, with an increasing emphasis on technological advancements and collaborations to optimize treatment efficacy while focusing on patient-centric approaches and cost management to drive growth.

KEY MARKET STATISTICS
Base Year [2023] USD 5.69 billion
Estimated Year [2024] USD 6.01 billion
Forecast Year [2030] USD 8.50 billion
CAGR (%) 5.88%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Lung Cancer Surgery Market

The Lung Cancer Surgery Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidence of lung cancer coupled with growing trend of smoking tobacco
    • Increasing emphasis on early diagnosis & treatment of cancers
    • Growing adoption of minimally invasive techniques
  • Market Restraints
    • High cost of lung cancer diagnosis & treatments
  • Market Opportunities
    • Rising technological advancements in lung cancer treatment
    • Availability of reimbursements policies and government support for cancer treatments
  • Market Challenges
    • Shortage of trained professionals

Porter's Five Forces: A Strategic Tool for Navigating the Lung Cancer Surgery Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Lung Cancer Surgery Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Lung Cancer Surgery Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Lung Cancer Surgery Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Lung Cancer Surgery Market

A detailed market share analysis in the Lung Cancer Surgery Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Lung Cancer Surgery Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Lung Cancer Surgery Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Lung Cancer Surgery Market

A strategic analysis of the Lung Cancer Surgery Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Lung Cancer Surgery Market, highlighting leading vendors and their innovative profiles. These include Accuray Inc., Ackermann Instrumente GmbH, AngioDynamics Inc., Baxter Healthcare Corporation, FusionKraft Surgical Instruments, Henry Schein, Inc., Intuitive Surgical Inc., Johnson & Johnson Services, Inc., KARL STORZ GmbH, Key Surgical LLC by STERIS plc, KLS Martin Group, Koninklijke Philips N.V., Medtronic PLC, Olympus Corporation, Richard Wolf GmbH, Scanlan International Inc., Siemens Healthineers AG, Sontec Instruments Inc., Teleflex Incorporated, TROKAMED GmbH, and Wexler Surgical Inc..

Market Segmentation & Coverage

This research report categorizes the Lung Cancer Surgery Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Surgical Devices, market is studied across Endo Surgical Equipment, Monitoring & Visualizing Systems, and Surgical Instruments. The Monitoring & Visualizing Systems is further studied across Cameras & Video Support and Endoscopic Trocars with Optical Views. The Surgical Instruments is further studied across Hand Instruments and Powered Surgical Equipment. The Hand Instruments is further studied across Clamps, Cutters, Elevators, Foreceps, Retractors, Rib Shears, Scissors, Staplers, and Trocar.
  • Based on Surgical Procedures, market is studied across Minimally Invasive Surgeries and Thoracotomy. The Thoracotomy is further studied across Lobectomy, Pneumenectomy, Segmentectomy, and Sleeve Resection.
  • Based on End-user, market is studied across Hospitals and Specialized Cancer Treatment Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of lung cancer coupled with growing trend of smoking tobacco
      • 5.1.1.2. Increasing emphasis on early diagnosis & treatment of cancers
      • 5.1.1.3. Growing adoption of minimally invasive techniques
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of lung cancer diagnosis & treatments
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising technological advancements in lung cancer treatment
      • 5.1.3.2. Availability of reimbursements policies and government support for cancer treatments
    • 5.1.4. Challenges
      • 5.1.4.1. Shortage of trained professionals
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Surgical Devices: Technological advancements in the monitoring and visualizing systems to enhance the complex surgery procedures of lung cancer
    • 5.2.2. Surgical Procedures: Growing preference for minimally invasive surgeries in lung cancer due to their adventages in reducing pain and fast recovery
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Lung Cancer Surgery Market, by Surgical Devices

  • 6.1. Introduction
  • 6.2. Endo Surgical Equipment
  • 6.3. Monitoring & Visualizing Systems
    • 6.3.1. Cameras & Video Support
    • 6.3.2. Endoscopic Trocars with Optical Views
  • 6.4. Surgical Instruments
    • 6.4.1. Hand Instruments
      • 6.4.1.1. Clamps
      • 6.4.1.2. Cutters
      • 6.4.1.3. Elevators
      • 6.4.1.4. Foreceps
      • 6.4.1.5. Retractors
      • 6.4.1.6. Rib Shears
      • 6.4.1.7. Scissors
      • 6.4.1.8. Staplers
      • 6.4.1.9. Trocar
    • 6.4.2. Powered Surgical Equipment

7. Lung Cancer Surgery Market, by Surgical Procedures

  • 7.1. Introduction
  • 7.2. Minimally Invasive Surgeries
  • 7.3. Thoracotomy
    • 7.3.1. Lobectomy
    • 7.3.2. Pneumenectomy
    • 7.3.3. Segmentectomy
    • 7.3.4. Sleeve Resection

8. Lung Cancer Surgery Market, by End-user

  • 8.1. Introduction
  • 8.2. Hospitals
  • 8.3. Specialized Cancer Treatment Centers

9. Americas Lung Cancer Surgery Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Lung Cancer Surgery Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Lung Cancer Surgery Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Novartis Enhances Cancer Treatment Capabilities with Acquisition of Mariana Oncology
    • 12.3.2. Expansion of Harmonic Clinical Trial, A New Frontier in NSCLC Treatment for Never-Smokers in East Asia
    • 12.3.3. Pioneering Transplant Program Offers New Lease on Life for Stage 4 Lung Cancer Patients
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Accuray Inc.
  • 2. Ackermann Instrumente GmbH
  • 3. AngioDynamics Inc.
  • 4. Baxter Healthcare Corporation
  • 5. FusionKraft Surgical Instruments
  • 6. Henry Schein, Inc.
  • 7. Intuitive Surgical Inc.
  • 8. Johnson & Johnson Services, Inc.
  • 9. KARL STORZ GmbH
  • 10. Key Surgical LLC by STERIS plc
  • 11. KLS Martin Group
  • 12. Koninklijke Philips N.V.
  • 13. Medtronic PLC
  • 14. Olympus Corporation
  • 15. Richard Wolf GmbH
  • 16. Scanlan International Inc.
  • 17. Siemens Healthineers AG
  • 18. Sontec Instruments Inc.
  • 19. Teleflex Incorporated
  • 20. TROKAMED GmbH
  • 21. Wexler Surgical Inc.

LIST OF FIGURES

  • FIGURE 1. LUNG CANCER SURGERY MARKET RESEARCH PROCESS
  • FIGURE 2. LUNG CANCER SURGERY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL LUNG CANCER SURGERY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. LUNG CANCER SURGERY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. LUNG CANCER SURGERY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. LUNG CANCER SURGERY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL LUNG CANCER SURGERY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. LUNG CANCER SURGERY MARKET DYNAMICS
  • TABLE 7. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ENDO SURGICAL EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY CAMERAS & VIDEO SUPPORT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ENDOSCOPIC TROCARS WITH OPTICAL VIEWS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY CLAMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY CUTTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ELEVATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY FORECEPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY RETRACTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY RIB SHEARS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SCISSORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY STAPLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY TROCAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY POWERED SURGICAL EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY LOBECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY PNEUMENECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SEGMENTECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SLEEVE RESECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SPECIALIZED CANCER TREATMENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 94. AUSTRALIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 96. AUSTRALIA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 101. CHINA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 102. CHINA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 103. CHINA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 108. INDIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 109. INDIA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 110. INDIA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 115. INDONESIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 116. INDONESIA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 117. INDONESIA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 122. JAPAN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 123. JAPAN LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 124. JAPAN LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 129. MALAYSIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 130. MALAYSIA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 131. MALAYSIA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 136. PHILIPPINES LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 137. PHILIPPINES LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 138. PHILIPPINES LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 143. SINGAPORE LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 144. SINGAPORE LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 145. SINGAPORE LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 150. SOUTH KOREA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 151. SOUTH KOREA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 152. SOUTH KOREA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 157. TAIWAN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 158. TAIWAN LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 159. TAIWAN LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 164. THAILAND LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 165. THAILAND LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 166. THAILAND LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 171. VIETNAM LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 172. VIETNAM LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 173. VIETNAM LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 186. DENMARK LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 187. DENMARK LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 188. DENMARK LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 193. EGYPT LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 194. EGYPT LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 195. EGYPT LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 200. FINLAND LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 201. FINLAND LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 202. FINLAND LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 207. FRANCE LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 208. FRANCE LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 209. FRANCE LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 214. GERMANY LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 215. GERMANY LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 216. GERMANY LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 221. ISRAEL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 222. ISRAEL LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 223. ISRAEL LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 228. ITALY LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 229. ITALY LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 230. ITALY LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 235. NETHERLANDS LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 236. NETHERLANDS LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 237. NETHERLANDS LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 241. NIGERIA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 242. NIGERIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 243. NIGERIA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 244. NIGERIA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 248. NORWAY LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 249. NORWAY LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 250. NORWAY LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 251. NORWAY LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 255. POLAND LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 256. POLAND LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 257. POLAND LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 258. POLAND LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 262. QATAR LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 263. QATAR LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 264. QATAR LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 265. QATAR LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 269. RUSSIA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 270. RUSSIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 271. RUSSIA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 272. RUSSIA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 276. SAUDI ARABIA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 277. SAUDI ARABIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 278. SAUDI ARABIA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 279. SAUDI ARABIA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 284. SOUTH AFRICA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 285. SOUTH AFRICA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 286. SOUTH AFRICA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 290. SPAIN LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 291. SPAIN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 292. SPAIN LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 293. SPAIN LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 298. SWEDEN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 299. SWEDEN LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 300. SWEDEN LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 305. SWITZERLAND LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 306. SWITZERLAND LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 307. SWITZERLAND LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 310. TURKEY LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 311. TURKEY LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 312. TURKEY LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 313. TURKEY LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 314. TURKEY LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED ARAB EMIRATES LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED ARAB EMIRATES LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED ARAB EMIRATES LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED ARAB EMIRATES LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED ARAB EMIRATES LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED ARAB EMIRATES LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED ARAB EMIRATES LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED KINGDOM LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED KINGDOM LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 324. UNITED KINGDOM LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 325. UNITED KINGDOM LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 326. UNITED KINGDOM LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 327. UNITED KINGDOM LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 328. UNITED KINGDOM LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 329. LUNG CANCER SURGERY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 330. LUNG CANCER SURGERY MARKET, FPNV POSITIONING MATRIX,